FindMyKOL
Clinical trialNCT01893619UnknownObservational

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

NCT01893619 is an observational study sponsored by New York CFS Association. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies Chronic Fatigue Syndrome. The registry lists an enrollment of 100 participants at 1 site in 1 country. The registry lists a start date of 30 Jun 2013 and a primary completion date of 31 Dec 2013.

SponsorNew York CFS AssociationEnrollment100Chronic Fatigue Syndrome
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01893619
FieldValue
Registry IDNCT01893619
StatusUnknown
Study typeObservational study
Lead sponsorNew York CFS Association
Enrollment100
Registered sites1
Countries1
ConditionsChronic Fatigue Syndrome
Start30 Jun 2013
Primary completion31 Dec 2013
Study completion31 Dec 2013
Last update posted25 Jul 2013

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site, 1 recruiting
  • Me/cfs Center,860 Fifth Avenue

    New York

    derek enlander, md
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 site, 1 recruitingNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01893619

Each answer restates registry values shown on this page.

What is NCT01893619?

NCT01893619 is an observational study sponsored by New York CFS Association. It studies Chronic Fatigue Syndrome.

Who leads NCT01893619?

The registry names DEREK enlander (principal investigator, CFIDS RESEARCH FOUNDATION) as the overall official.

Where does NCT01893619 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT01893619 expected to complete?

The registry lists a primary completion date of 31 Dec 2013 and a study completion date of 31 Dec 2013. The sponsor last updated the record on 25 Jul 2013.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.